Loading...

Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study

BACKGROUND: Indacaterol is a long-acting beta-2 agonist for once-daily treatment of COPD. We evaluated the effects of indacaterol 150 μg on lung hyperinflation compared with placebo and open-label tiotropium 18 μg. We measured physical activity during treatment with indacaterol 150 μg and matched pl...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Watz, Henrik, Krippner, Felix, Kirsten, Anne, Magnussen, Helgo, Vogelmeier, Claus
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4197315/
https://ncbi.nlm.nih.gov/pubmed/25280934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-14-158
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!